Luramist - The technology has advanced a lot in every field including the medical field.
The medical field has made a lot of advanced researches in everything that the human world is facing in the name of Disease. Here the term Luramist is again a medical term that describes the research made by the research scholars in the female sexual; dysfunction found in the female body. In general, Luramist is an easy to use model of equipment, small in size, a hand held transdermal spray containing the Testosterone and a proprietary skin penetration enhancer. This has enhanced or made a gradual increase in the increasing of the number of satisfying sexual events in pre-menopausal patients with HSDD. This has made a significant growth in the research module a different answer that has made them to make their concentration again towards this point.
Clinical Trials of Luramist
The details study made by the Australian group of researches here has showed a significant improvement. Their first phase of research to evaluate the pharmacokinetic profile of the Luramist and to determine the optimal physiologic replacement doses which provided a demonstration that the MDTS (Metered Dose Transdermal Spray) has the capacity of providing a sustained or a continued delivery of the testosterone for a period of about a day and also supports in restoring the physiological blood levels to the mid to high normal range in a woman with a low testosterone. As a result of this they have made further analysis in the study of the Luramist, they have reached yet another point where they have arrived with a significant improvement in the number of support sexual events in pre-menopausal patients with HSDD. The research group has made this study with a particular number of women to find a statistical review and also a research in the study of finding the actual root cause in finding the result for the issue the women are facing in their life.
This is somewhat a study related to the women health and also a study that helps in finding a way to make some rectification to set a free life further. This is a health related study or research. In general, this is a study regarding the special protocol assessment made by the research group for the third phase of effective analysis of the trials for the Luramist, the testosterone metered dose transdermal spray that is applied in this study for the treatment of the hypoactive sexual desire disorder (HSDD) or low libido in women. This has made an effective improvement and has given a wide information on the study including the scope and the size of the patient population studied, the primary endpoints focused, the criteria of inclusion and the exclusion, the period or the time scale of the trials and the essential requirements of the trials of the statistical research or the analysis.
The analysis or the brief as well as the in depth study of the topic has been made under several time duration to find an exact outcome to make an exclusive treatment and to find the exact study of the menopause in women for a duration of six months of treatment. The basic in this study is an increase in the sexual desire and the total number of increased satisfying sexual events, with a secondary stage of a decrease in the sexual distress.
For now Luramist seems to have suffered the same fate as Flibanserin and more recently LibiGel by BioSante. This appears to be a trend in the pharmaceutical industry that is shrouded wiht a lot of critisism and conspiracy as there was such a fast track for male formulas such as Viagra and Cialis.
- Written by:
- Sandy Major